These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 37047638)

  • 1. The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs.
    Markov DD; Dolotov OV; Grivennikov IA
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
    Masi G; Brovedani P
    CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmunology of depression.
    Sarno E; Moeser AJ; Robison AJ
    Adv Pharmacol; 2021; 91():259-292. PubMed ID: 34099111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic N-terminal fragments of adrenocorticotropin reduce inflammation- and stress-induced anhedonia in rats.
    Markov DD; Yatsenko KA; Inozemtseva LS; Grivennikov IA; Myasoedov NF; Dolotov OV
    Psychoneuroendocrinology; 2017 Aug; 82():173-186. PubMed ID: 28551512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin as a putative antidepressant.
    Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
    Pariante CM; Miller AH
    Biol Psychiatry; 2001 Mar; 49(5):391-404. PubMed ID: 11274650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression.
    Kunugi H; Hori H; Adachi N; Numakawa T
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):447-59. PubMed ID: 20923424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-3 PUFA Have Antidepressant-like Effects Via Improvement of the HPA-Axis and Neurotransmission in Rats Exposed to Combined Stress.
    Kim EY; Choi JE; Kim M; Hong J; Park Y
    Mol Neurobiol; 2020 Sep; 57(9):3860-3874. PubMed ID: 32613466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin as a target for antidepressant development: an assessment of the available evidence.
    Scott LV; Dinan TG
    J Affect Disord; 2002 Nov; 72(2):113-24. PubMed ID: 12200202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.
    Mahar I; Bambico FR; Mechawar N; Nobrega JN
    Neurosci Biobehav Rev; 2014 Jan; 38():173-92. PubMed ID: 24300695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
    Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
    J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurobiological mechanisms of depression and antidepressant therapy].
    Shishkina GT; Dygalo NN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(2):138-52. PubMed ID: 20469588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.
    Barden N
    J Psychiatry Neurosci; 2004 May; 29(3):185-93. PubMed ID: 15173895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
    Kopschina Feltes P; Doorduin J; Klein HC; Juárez-Orozco LE; Dierckx RA; Moriguchi-Jeckel CM; de Vries EF
    J Psychopharmacol; 2017 Sep; 31(9):1149-1165. PubMed ID: 28653857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenesis and antidepressant action.
    Park SC
    Cell Tissue Res; 2019 Jul; 377(1):95-106. PubMed ID: 31165247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in genes related to the hypothalamic-pituitary-adrenal axis and antidepressant response - Systematic review.
    Fischer S; Gardini ES; Haas F; Cleare AJ
    Neurosci Biobehav Rev; 2019 Jan; 96():182-196. PubMed ID: 30465786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.